Primary chemotherapy and delayed surgery for non-metastatic telangiectatic osteosarcoma of the extremities. Results in 28 patients
Authors:
- P. PicciPPP. Picci
- S. FerrariSFS. Ferrari
- L. SangiorgiLSL. Sangiorgi
- A. ZanoneAZA. Zanone
- A. Brach del PreverAPA. Brach del Prever
- 1 January 1994
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 30 (5) , 620-626
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Telangiectatic OsteosarcomaClinical Orthopaedics and Related Research, 1991
- Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86)Cancer, 1990
- Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities the istituto rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatinCancer, 1990
- Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.Journal of Clinical Oncology, 1988
- Telangiectatic Osteogenic SarcomaClinical Orthopaedics and Related Research, 1986
- Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy regional mapping of viable and nonviable tumorCancer, 1985
- Preoperative (Neoadjuvant) Chemotherapy for Osteogenic Sarcoma: A Ten Year ExperienceOrthopedics, 1985
- Telangiectatic osteogenic sarcoma: A clinicopathologic study of 124 patientsCancer, 1982
- Telangiectatic OsteosarcomaActa Orthopaedica, 1978
- Telangiectatic osteogenic sarcomaCancer, 1976